Application 209529
- Type
- NDA
- Sponsor
- ASTELLAS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VESICARE LS | SOLIFENACIN SUCCINATE | SUSPENSION;ORAL | 5MG/5ML(1MG/ML) | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209529-001 | VESICARE LS | SOLIFENACIN SUCCINATE | 1MG/ML | SUSPENSION / ORAL | RLD | 2020-05-26 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD | 2020-05-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD | 2020-05-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD | 2020-05-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD | 2020-05-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD | 2020-05-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | c0c555d07b60… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD, RS | 2020-05-26 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N209529-001 | VESICARE LS | 1MG/ML | SUSPENSION / ORAL | RLD | 2020-05-26 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 87673890dc5c… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N209529-001 | 9918970 | 2031-05-18 | Drug product | 2021-03-11 | a50c72e98297… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209529-001 | NP | 2023-05-26 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209529-001 | PED | 2023-11-26 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N209529-001 | NP | 2023-05-26 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209529-001 | PED | 2023-11-26 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N209529-001 | NP | 2023-05-26 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N209529-001 | PED | 2023-11-26 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N209529-001 | NP | 2023-05-26 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N209529-001 | PED | 2023-11-26 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N209529-001 | NP | 2023-05-26 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N209529-001 | PED | 2023-11-26 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209529-001 | NP | 2023-05-26 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209529-001 | PED | 2023-11-26 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N209529-001 | NP | 2023-05-26 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N209529-001 | PED | 2023-11-26 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N209529-001 | NP | 2023-05-26 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N209529-001 | PED | 2023-11-26 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N209529-001 | NP | 2023-05-26 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N209529-001 | PED | 2023-11-26 | c0c555d07b60… |
| 2023-12-20 04:57 UTC | 2023-12 | N209529-001 | NP | 2023-05-26 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N209529-001 | W | 2023-11-26 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209529-001 | NP | 2023-05-26 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N209529-001 | W | 2023-11-26 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209529-001 | NP | 2023-05-26 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N209529-001 | W | 2023-11-26 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N209529-001 | NP | 2023-05-26 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N209529-001 | PED | 2023-11-26 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N209529-001 | NP | 2023-05-26 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N209529-001 | PED | 2023-11-26 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N209529-001 | NP | 2023-05-26 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N209529-001 | PED | 2023-11-26 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N209529-001 | NP | 2023-05-26 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N209529-001 | PED | 2023-11-26 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N209529-001 | NP | 2023-05-26 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N209529-001 | PED | 2023-11-26 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N209529-001 | NP | 2023-05-26 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N209529-001 | PED | 2023-11-26 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N209529-001 | NP | 2023-05-26 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N209529-001 | PED | 2023-11-26 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N209529-001 | NP | 2023-05-26 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N209529-001 | PED | 2023-11-26 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Solifenacin succinate | SOLIFENACIN SUCCINATE | Proficient Rx LP | b20003a6-f781-4563-9824-3e8b97c763c6 | 2024-01-01 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin succinate | SOLIFENACIN SUCCINATE | Actavis Pharma, Inc. | 02e2aa54-1ed8-445a-a082-ac2c64b339fe | 2023-11-28 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Proficient Rx LP | 8ab4f222-018f-40fc-a6aa-39dab563a8a0 | 2023-11-01 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Proficient Rx LP | 70fece2c-a59f-43f9-abbf-ac67500e90bb | 2022-09-01 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| solifenacin succinate | SOLIFENACIN SUCCINATE | Camber Pharmaceuticals, Inc. | 6479d24f-373e-4c9e-abaf-349f90a2bbb1 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Proficient Rx LP | c67107f4-348b-4a23-a67c-26fd8241ebd6 | 2022-06-01 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Alembic Pharmaceuticals Inc. | 48f82298-6600-4c69-a638-8dae15083fd9 | 2021-12-07 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Unichem Pharmaceuticals (USA), Inc. | 51ff19b4-09ac-4796-8869-671ddd62c578 | 2021-10-22 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Proficient Rx LP | d6525817-bea1-4a4c-bed4-4873ee202cc8 | 2021-05-01 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| SOLIFENACIN SUCCINATE | SOLIFENACIN SUCCINATE | ScieGen Pharmaceuticals, Inc. | a6f154d9-7463-4b80-b80e-c06a06e36141 | 2021-01-19 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Novadoz Pharmaceuticals LLC | 98b99a4c-201d-46ee-b78c-7634a64d3a8d | 2020-06-01 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
| Solifenacin Succinate | SOLIFENACIN SUCCINATE | Alembic Pharmaceuticals Limited | aea71cde-6d62-4f8d-b813-47064cb213d9 | 2019-05-22 | Warnings, Adverse reactions | SOLIFENACIN SUCCINATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51248-250 | VESIcare | solifenacin succinate | Astellas Pharma US, Inc. | NDA | Current |
| 51248-250 | VESIcare | solifenacin succinate | Astellas Pharma US, Inc. | NDA | Current |
| 51248-250 | VESIcare | solifenacin succinate | Astellas Pharma US, Inc. | NDA | Current |